Role of Positron Emission Tomography-Computed Tomography Scan in Reaching Definite Diagnosis in Patients With Fever of Unknown Origin and Inflammation of Unknown Origin in Rheumatology Outpatient Clinic
Open Access
- 1 February 2025
- journal article
- research article
- Published by Taylor & Francis in Open Access Rheumatology: Research and Reviews
- Vol. ume 17, 25-32
Abstract
Introduction: Patients with fever of unknown origin (FUO) and/or inflammation of unknown origin (IUO) challenge clinicians in daily rheumatology practice. Positron emission tomography-computed tomography (PET/CT) is being used in the diagnostic workup of patients with FUO and/or IUO. This study aims to evaluate the clinical utility and diagnostic performance of PET/CT in the rheumatology outpatient clinic among FUO and IUO patients. Methods: Patients admitted to Prof. Dr. Cemil Taşcıoğlu City Hospital Internal Medicine Rheumatology Outpatient Clinic between February 2022 and September 2023 with FUO and/or IUO and for whom PET/CT scan was performed were included. Initial acute phase reactants, PET/CT results, definite diagnosis and follow-up of patients without a definite diagnosis were retrospectively evaluated. Results: Thirty patients were included. Fifteen patients received a final diagnosis. Diagnoses were ankylosing spondylitis (n=4), rheumatoid arthritis (n=1), systemic lupus erythematosus (n=3), giant cell arteritis (n=1), adult onset Still disease (n=1), undifferentiated connective tissue disease (n=1), undifferentiated vasculitis (n=1) and crystal arthropathy (n=1), Hodgkin lymphoma (n=1) and cryptococcosis (n=1). PET/CT’s diagnostic accuracy was 66.7%, sensitivity was 100% but specificity was 33%. In 15 patients a definite diagnosis was not reached but in most of these patients, fever did not recur and acute phase reactants regressed either spontaneously or with empiric treatment. Discussion: PET/CT reliably helps 50% FUO/IUO patients in receiving definite diagnosis. PET/CT’s high sensitivity implies that negative results can reliably exclude malignancies in most cases. However, due to its low specificity, positive test may not always imply a serious underlying condition. Majority of the definite diagnoses were rheumatic diseases with a very low proportion of infections and malignancies. This is mainly due to the detailed initial evaluations that are performed in internal medicine clinics. Future studies with more patients will better define the role of PET/CT in FUO/IUO patients in rheumatology clinics.Keywords
This publication has 23 references indexed in Scilit:
- Predictors for spontaneous resolution of classical FUO in patients undergoing PET-CTInternal and Emergency Medicine, 2022
- Fluorine-18 labeled fluorodeoxyglucose positron emission tomography/computed tomography used in diagnosing connective tissue diseases in fever of unknown origin/inflammatory of unknown origin patientsClinical Rheumatology, 2021
- Predictive value of semi-quantitative index from F-18-fluoride PET/CT for treatment response in patients with ankylosing spondylitisEuropean Journal of Radiology, 2020
- PET/CT for Diagnosis and Management of Large-Vessel VasculitisCurrent Cardiology Reports, 2019
- Fever of Unknown Origin: the Value of FDG-PET/CTSeminars in Nuclear Medicine, 2018
- Do clinical and laboratory variables have any impact on the diagnostic performance of 18F-FDG PET/CT in patients with fever of unknown origin?Annals of Nuclear Medicine, 2017
- Diagnostic yield of FDG-PET/CT in fever of unknown origin: a systematic review, meta-analysis, and Delphi exerciseClinical Radiology, 2017
- 18F-FDG PET/CT in patients with adult-onset Still’s diseaseClinical Rheumatology, 2015
- Diagnostic value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with fever of unknown originEuropean Journal of Internal Medicine, 2011
- Fever of unknown origin: A value of 18F-FDG-PET/CT with integrated full diagnostic isotropic CT imagingEuropean Journal of Radiology, 2010